D
Debra A. Bergman
Researcher at University of Nebraska Medical Center
Publications - 11
Citations - 579
Debra A. Bergman is an academic researcher from University of Nebraska Medical Center. The author has contributed to research in topics: Hazard ratio & Population. The author has an hindex of 7, co-authored 11 publications receiving 511 citations.
Papers
More filters
Journal ArticleDOI
Periodontitis and Porphyromonas gingivalis in patients with rheumatoid arthritis.
Ted R. Mikuls,Jeffrey B. Payne,Fang Yu,Geoffrey M. Thiele,Richard J. Reynolds,Grant W. Cannon,Jeffrey Markt,David McGowan,Gail S. Kerr,Robert S. Redman,Andreas M. Reimold,Garth R. Griffiths,Mark W. Beatty,Shawneen M. Gonzalez,Debra A. Bergman,Bartlett C. Hamilton,Alan R Erickson,Jeremy Sokolove,William H. Robinson,Clay Walker,Fatiha Chandad,James R. O'Dell +21 more
TL;DR: To examine the degree to which shared risk factors explain the relationship of periodontitis to rheumatoid arthritis (RA) and to determine the associations of PD and Porphyromonas gingivalis with pathologic and clinical features of RA.
Journal ArticleDOI
Localization of nicotinic cholinergic receptors in rat brain: autoradiographic studies with [3H]cytisine.
TL;DR: The agonist [3H]cytisine proves to be an excellent marker for nicotinic cholinergic receptors with a very high affinity and very low background and there are significant variations and gradients in receptor density within specific brain regions, including subregions previously thought to be homogeneous.
Journal ArticleDOI
Localization and quantification of the dopamine transporter: comparison of [3H]WIN 35,428 and [125I]RTI-55
TL;DR: Differences in transporter density could reflect different forms of the transporter, perhaps due to post-translational modifications, and they may provide a basis for differential pharmacological regulation of transporter function in discrete brain regions and disease states.
Journal ArticleDOI
Prospective Study of Survival Outcomes in Non-Hodgkin's Lymphoma Patients With Rheumatoid Arthritis
Ted R. Mikuls,Justin O. Endo,Susan E. Puumala,Patricia Aoun,Natalie A. Black,James R. O'Dell,Julie A. Stoner,Eugene Boilesen,Martin Bast,Debra A. Bergman,Kay M. Ristow,Melissa Ooi,James O. Armitage,Thomas M. Habermann +13 more
TL;DR: RA is associated with improved NHL-related outcomes, including a 40% reduced risk of death occurring as a result of lymph cancer or its treatment and approximately a 60% lower risk of lymphoma relapse or progression compared with non-RA controls, however, the survival advantage gained in RA from the acquisition of lymphomas with favorable prognoses is negated through an increased mortality from other comorbid conditions.
Journal ArticleDOI
Allopurinol Dose Escalation and Mortality Among Patients With Gout: A National Propensity-Matched Cohort Study.
TL;DR: The aim of the current study was to determine whether allopurinol dose escalation is associated with cause‐specific mortality in patients with gout.